NICE, together with NHS England, remains committed to working with the company to try to reach a long-term deal that will give access to cerliponase alfa to all eligible people after that time.

12 SQ-HDM SLIT for treating allergic rhinitis or rhinoconjunctivitis caused by house dust mites in children 5 to 11 years [ID6510] Technology appraisal guidance Abatacept for treating active ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.